SCHEMBL2493981

SCHEMBL2493981

C1=Cc2c(-c3cccs3)ccnc2[N]1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.41
ALDH1A1 P00352 5/20 0.41
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
GAA P10253 3/20 0.38
HPGD P15428 3/20 0.38
GLA P06280 2/20 0.38
GFER P55789 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
MAPT P10636 2/20 0.37
NPC1 O15118 1/20 0.37
CCNA2 P20248 1/20 0.36
CDK2 P24941 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
HTR2B P41595 1/20 0.36
TOP2A P11388 1/20 0.36
CDK5 Q00535 2/20 0.36
LTK P29376 1/20 0.36
MST1R Q04912 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11904054 0.90 DPP4 (0.38) KDM4EALDH1A1MEN1KMT2AGAA
SCHEMBL11903820 0.83 PRKDC (0.36) KDM4EALDH1A1MEN1KMT2AGAA
SCHEMBL11903855 0.76 HSP90AA1 (0.36) TGFBR1CYP2A6
SCHEMBL2493833 0.75 NPC1 (0.43) KDM4EALDH1A1MEN1KMT2AGAA
SCHEMBL28083058 0.71 TOP2A (0.49) KDM4EALDH1A1MEN1KMT2AGAA
SCHEMBL2497304 0.71 KDM4E (0.38) KDM4EALDH1A1MEN1KMT2AGAA
SCHEMBL3358739 0.67 TOP2A (0.59) KDM4EALDH1A1MEN1KMT2AGAA
SCHEMBL28755209 0.66 CDK5 (0.45) KDM4EALDH1A1MEN1KMT2AGAA
SCHEMBL2495572 0.66 KDM4E (0.50) KDM4EALDH1A1MEN1KMT2AGAA
SCHEMBL8087934 0.65 TGFBR1 (0.65) KDM4EALDH1A1MEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220315926-A1 An Aptamer for Dengue Virus and Related Methods and Products AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2022-10-06 US claimed
EP-3987035-A1 AN APTAMER FOR DENGUE VIRUS AND RELATED METHODS AND PRODUCTS Agency for Science, Technology and Research (SG) 2022-04-27 EP claimed
EP-3918091-A1 METHOD OF SEQUENCING NUCLEIC ACID WITH UNNATURAL BASE PAIRS Agency for Science, Technology and Research (SG) 2021-12-08 EP claimed
CN-113518830-A Method for sequencing nucleic acids with unnatural base pairing 新加坡科技研究局 2021-10-19 CN claimed
WO-2020256639-A1 AN APTAMER FOR DENGUE VIRUS AND RELATED METHODS AND PRODUCTS AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2020-12-24 WO claimed
WO-2020159435-A1 METHOD OF SEQUENCING NUCLEIC ACID WITH UNNATURAL BASE PAIRS AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2020-08-06 WO claimed
EP-1970445-B1 METHOD FOR NUCLEIC ACID REPLICATION AND NOVEL ARTIFICIAL BASE PAIRS RIKEN (JP) 2012-09-26 EP claimed
US-8030478-B2 Method for nucleic acid replication and novel artificial base pairs RIKEN (JP) 2011-10-04 US claimed
US-20100036111-A1 METHOD FOR REPLICATING NUCLEIC ACIDS AND NOVEL UNNATURAL BASE PAIRS RIKEN (JP) 2010-02-11 US claimed
EP-1970445-A1 METHOD FOR NUCLEIC ACID REPLICATION AND NOVEL ARTIFICIAL BASE PAIRS Riken (JP) 2008-09-17 EP claimed
US-20220315926-A1 An Aptamer for Dengue Virus and Related Methods and Products AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2022-10-06 US disclosed
EP-3987035-A1 AN APTAMER FOR DENGUE VIRUS AND RELATED METHODS AND PRODUCTS Agency for Science, Technology and Research (SG) 2022-04-27 EP disclosed
EP-3918091-A1 METHOD OF SEQUENCING NUCLEIC ACID WITH UNNATURAL BASE PAIRS Agency for Science, Technology and Research (SG) 2021-12-08 EP disclosed
CN-113518830-A Method for sequencing nucleic acids with unnatural base pairing 新加坡科技研究局 2021-10-19 CN disclosed
WO-2020256639-A1 AN APTAMER FOR DENGUE VIRUS AND RELATED METHODS AND PRODUCTS AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2020-12-24 WO disclosed
US-20120231462-A1 ARTIFICIAL BASE PAIR CAPABLE OF FORMING SPECIFIC BASE PAIR TAGCYX BIOTECHNOLOGIES (JP) 2012-09-13 US disclosed
EP-2487181-A1 ARTIFICIAL BASE PAIR CAPABLE OF FORMING SPECIFIC BASE PAIR Riken (JP) 2012-08-15 EP disclosed
US-8030478-B2 Method for nucleic acid replication and novel artificial base pairs RIKEN (JP) 2011-10-04 US disclosed
US-20100036111-A1 METHOD FOR REPLICATING NUCLEIC ACIDS AND NOVEL UNNATURAL BASE PAIRS RIKEN (JP) 2010-02-11 US disclosed
EP-1970445-A1 METHOD FOR NUCLEIC ACID REPLICATION AND NOVEL ARTIFICIAL BASE PAIRS Riken (JP) 2008-09-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100036111-A1 METHOD FOR REPLICATING NUCLEIC ACIDS AND NOVEL UNNATURAL BASE PAIRS POLM, POLL, POLRMT KDM4E 1933/4885ALDH1A1 2586/4885MEN1 4033/4885
US-20120231462-A1 ARTIFICIAL BASE PAIR CAPABLE OF FORMING SPECIFIC BASE PAIR NSUN2, EIF2AK2, NSUN3 KDM4E 3694/4885ALDH1A1 1963/4885MEN1 3875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.